Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
08/21/1994 | CA2115966A1 Chrysospermins, active peptides from apiocrea chrysosperma having a pharmacological effect, a process for their preparation and the use thereof |
08/18/1994 | WO1994018562A1 Human carcinoma antigen (hca), hca antibodies, hca immunoassays, methods of imaging and therapy |
08/18/1994 | WO1994018560A1 Method of assaying human tau protein, kit therefor, and diagnostic method |
08/18/1994 | WO1994018341A1 Apparatus and process for continuous $i(in vitro) synthesis of peptides |
08/18/1994 | WO1994018339A1 Compositions and methods for protein structural determinations |
08/18/1994 | WO1994018330A1 Immobilized proteins with specific binding capacities and their use in processes and products |
08/18/1994 | WO1994018329A2 Serine protease variants having peptide ligase activity |
08/18/1994 | WO1994018327A1 Fibronectin binding protein; monoclonal antibody and their use in preventing bacterial adhesion |
08/18/1994 | WO1994018325A1 Tnf-alpha muteins and a process for preparing them |
08/18/1994 | WO1994018324A2 Phospho-specific antibodies against transcription factors, more specifically against a creb derived peptide |
08/18/1994 | WO1994018323A1 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
08/18/1994 | WO1994018322A1 HTLV-I AND HTLV-II gp21 DERIVED PEPTIDES FOR USE IN DIAGNOSTICS |
08/18/1994 | WO1994018319A1 Novel polypeptides having serotoninergic receptor activity, nucleic acids coding therefor and use thereof |
08/18/1994 | WO1994018318A1 Totally synthetic affinity reagents |
08/18/1994 | WO1994018317A1 Regulated transcription of targeted genes and other biological events |
08/18/1994 | WO1994018313A1 Functional domains in flavobacterium okeanokoites (foki) restriction endonuclease |
08/18/1994 | WO1994018309A1 Novel receptor-type phosphotyrosine phosphatase-gamma |
08/18/1994 | WO1994018308A1 Novel receptor-type phosphotyrosine phosphatase-beta |
08/18/1994 | WO1994018237A1 Novel peptide having receptor activity and dna coding for said peptide |
08/18/1994 | WO1994018227A2 Improved method for the refolding of proteins |
08/18/1994 | WO1994018222A1 Nuclear matrix proteins |
08/18/1994 | WO1994017828A2 Treatment for insulin dependent diabetes |
08/18/1994 | WO1994017822A1 PULMONARY ADMINISTRATION OF sCR1 AND OTHER COMPLEMENT INHIBITORY PROTEINS |
08/18/1994 | WO1994014960A3 Protocadherin, their autibodies and uses |
08/18/1994 | WO1994011026A3 Therapeutic application of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma |
08/18/1994 | WO1994010203A3 Op-3-induced morphogenesis |
08/18/1994 | WO1994006454A3 Inhibitiion of retrovirus infection |
08/18/1994 | DE4311580C1 Glycoproteins, process for their preparation and pharmaceutical compositions containing them |
08/18/1994 | CA2155725A1 Novel receptor-type phosphotyrosine phosphatase-gamma |
08/18/1994 | CA2155646A1 Phospho-specific antibodies against a creb derived peptide |
08/18/1994 | CA2155645A1 Nuclear matrix proteins |
08/18/1994 | CA2155545A1 Novel receptor-type phosphotyrosine phosphatase-beta |
08/18/1994 | CA2155413A1 Fibronectin binding protein; monoclonal antibody and their use in preventing bacterial adhesion |
08/18/1994 | CA2155103A1 Tnf-alpha muteins and a process for preparing them |
08/18/1994 | CA2154266A1 Human carcinoma antigen (hca), hca antibodies, hca immunoassays, methods of imaging and therapy |
08/18/1994 | CA2153162A1 New polypeptides having serotoninergic receptor activity, nucleic acids coding therefor and uses thereof |
08/18/1994 | CA2129904A1 Compositions and methods for protein structural determinations |
08/17/1994 | EP0611080A1 Monoclonal antibody that distinguishes between phosphorylated and nonphosphorylated histone H1 |
08/17/1994 | EP0610842A2 Beta-Tubulin from Acremonium chrysogenum, preparation and use |
08/17/1994 | EP0610475A1 Enzymatically-produced dimeric il-2 and a nerve-derived transglutaminase enzyme for its preparation |
08/17/1994 | EP0610474A1 Animal cell culture |
08/17/1994 | EP0610427A1 TGF-$g(b) TYPE RECEPTOR cDNAS AND USES THEREFOR |
08/17/1994 | EP0610420A1 Cell cycle controlling compositions and methods of using same |
08/17/1994 | EP0610411A1 Casein hydrolyzate and method for production of such casein hydrolyzate. |
08/17/1994 | EP0610335A1 Recombitope peptides |
08/17/1994 | EP0610330A1 Monoclonal antibodies directed against the microtubule-associated protein tau. |
08/17/1994 | EP0610322A1 Helicobacter pylori genes necessary for the regulation and maturation of urease, and use thereof |
08/17/1994 | EP0610286A1 Recombinant immunotoxins |
08/17/1994 | EP0610254A1 Glial derived neurotrophic factor |
08/17/1994 | EP0610246A1 Novel thrombin-inhibiting protein from ticks |
08/17/1994 | EP0610211A1 Monoclonal antibodies specific for human thymidylate synthase |
08/17/1994 | EP0610201A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
08/17/1994 | EP0391960B1 Genetic modification of endothelial cells |
08/17/1994 | EP0265500B1 Antibody to human progesterone receptor and diagnostic materials and methods |
08/17/1994 | EP0248909B1 Anticytomegaloviral human monoclonal antibody and process for its preparation |
08/17/1994 | CN1090929A Immunoassay for isothiazolones |
08/17/1994 | CN1090928A Method for early detection, detection of the severity and for a treatment-accompanying assessment of the course of a sepsis, as well as a means for carrying out said method |
08/16/1994 | US5338858 Viricides |
08/16/1994 | US5338840 DNA encoding glioma-derived growth factor having vascular endothelial cell growth promoting activity |
08/16/1994 | US5338836 Biologically active porcine somatotropin polypeptides and methods of using the same |
08/16/1994 | US5338833 Carboxy terminal IL-6 muteins |
08/16/1994 | US5338683 Genetic engineering, vaccines |
08/16/1994 | US5338682 Starters for fermented foods which also suppress acid formation in milk during storage or transportation |
08/16/1994 | US5338676 Genetically engineered protein or enzyme |
08/16/1994 | US5338671 Reduce formation of non-specific products in polymerase chain reactions |
08/16/1994 | US5338668 Opioid peptides derived from wheat proteins |
08/16/1994 | US5338661 Monoclonal antibody specific for a human tumour-associated antigen |
08/13/1994 | CA2115507A1 .beta.-tubulin from acremonium chrysogenum, its preparation and use |
08/11/1994 | DE4404124A1 Mutierte Tumor-Nekrose-Faktor-Proteine Mutant tumor necrosis factor-proteins |
08/10/1994 | EP0610046A2 Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispesific fusion proteins in a mammalian cell |
08/10/1994 | EP0609901A1 T-cell receptor-specific for antigen polypeptides and related polynucleotides |
08/10/1994 | EP0609722A1 An in vitro method for detecting the presence of invasive stimuli in mammals |
08/10/1994 | EP0609580A1 Recombinant CMV neutralising proteins |
08/10/1994 | EP0609393A1 VIRULENCE ASSOCIATED PROTEINS IN $i(BORRELIA BURGDORFERI (Bb)) |
08/10/1994 | EP0609359A1 Dimorphism genes in fungi |
08/10/1994 | EP0609242A1 New thrombin-inhibiting protein isolated from ticks. |
08/10/1994 | EP0181929B1 Trans-acting transcriptional factors |
08/10/1994 | CN1090510A Interferon tau compositions and methods of use |
08/09/1994 | US5336758 AIDS vaccines |
08/09/1994 | US5336666 Immunostimulant drug based on polar glyopeptidolipids of mycobacterium chelonae |
08/09/1994 | US5336618 Monoclonal antibody of the class IgG1, designated 7E3, reacts readily with both normal human and dog blood platelets while fail to react with thrombasthenic human platelets |
08/09/1994 | US5336602 Transforming escherichia cell with DNA sequence and an expression vector, cultivation; genetic engineering; arginine |
08/09/1994 | US5336601 Enzymatic membrane method for the snythesis and separation of peptides |
08/09/1994 | CA1331356C Mutant human angiogenin (angiogenesis factor with superior angiogenin activity) genes therefor and methods of expression |
08/09/1994 | CA1331355C Immunopotentation |
08/06/1994 | CA2088878A1 Cdnas encoding the gastrin and cck-b receptors |
08/05/1994 | CA2114686A1 Mammalian influx peptide transporter |
08/04/1994 | WO1994017415A1 Novel anticoagulant cofactor activity |
08/04/1994 | WO1994017197A1 ANTIBODY AGAINST β-AMYLOID OR DERIVATIVE THEREOF AND USE THEREOF |
08/04/1994 | WO1994017193A2 Chimeric l- and p-selectin by exchange of domains - uses thereof |
08/04/1994 | WO1994017192A2 Lysosomal targeting of immunogens |
08/04/1994 | WO1994017189A2 Protein kinases |
08/04/1994 | WO1994017185A1 G-csf analog compositions and methods |
08/04/1994 | WO1994017184A1 Modulation of physiological responses of lymphocytes by cd38 or antibodies thereto |
08/04/1994 | WO1994017183A1 Agents for the prevention and treatment of lesch-nyhan syndrome |
08/04/1994 | WO1994017105A1 Human-murine chimeric antibodies against respiratory syncytial virus |
08/04/1994 | WO1994017101A1 Max-interacting proteins and related molecules and methods |
08/04/1994 | WO1994017100A1 Icam-related protein |
08/04/1994 | WO1994017087A1 Tata-binding protein associated factors, nucleic acids encoding tafs, and methods of use |
08/04/1994 | WO1994016730A1 Human monoclonal antibodies to cytomegalovirus |